Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Devogelaer

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 1, 1981
Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type IC N de Deuxchaisnes, J A Fischer, M A Dambacher, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 2, 2011
Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone ClubJ-J Body, P Bergmann, S Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2011
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosisJ-Y Reginster, J-M Kaufman, S Goemaere, et al.
Osteoarthritis and Cartilage|July 19, 2015
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statementJ-Y Reginster, S Reiter-Niesert, O Bruyère, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2005
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) studyJ Y Reginster, E Seeman, M C De Vernejoul, et al.
Calcified Tissue International|August 11, 2012
Management of glucocorticoid-induced osteoporosisR Rizzoli, J D Adachi, C Cooper, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Guidelines for clinical studies assessing the efficacy of drugs for the management of acute low back painJ P Devogelaer, R L Dreiser, E Abadie, et al.
Bone|December 4, 2012
Treatment of osteoporosis in menJ-M Kaufman, J-Y Reginster, S Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 23, 2007
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosisJ P Devogelaer, J P Brown, P Burckhardt, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Endocrinology and Metabolism|December 1, 1981
Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type IC N de Deuxchaisnes, J A Fischer, M A Dambacher, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 2, 2011
Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone ClubJ-J Body, P Bergmann, S Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2011
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosisJ-Y Reginster, J-M Kaufman, S Goemaere, et al.
Osteoarthritis and Cartilage|July 19, 2015
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statementJ-Y Reginster, S Reiter-Niesert, O Bruyère, et al.
The Journal of Clinical Endocrinology and Metabolism|February 25, 2005
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) studyJ Y Reginster, E Seeman, M C De Vernejoul, et al.
Calcified Tissue International|August 11, 2012
Management of glucocorticoid-induced osteoporosisR Rizzoli, J D Adachi, C Cooper, et al.
Annals of the Rheumatic Diseases|September 27, 2000
Background for studies on the treatment of male osteoporosis: state of the artJ M Kaufman, O Johnell, E Abadie, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Guidelines for clinical studies assessing the efficacy of drugs for the management of acute low back painJ P Devogelaer, R L Dreiser, E Abadie, et al.
Bone|December 4, 2012
Treatment of osteoporosis in menJ-M Kaufman, J-Y Reginster, S Boonen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 23, 2007
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosisJ P Devogelaer, J P Brown, P Burckhardt, et al.
Pageof 14